Prof. Murray Brunt on One-Week Breast Radiotherapy and FAST-FORWARD BOOST Study | ESTRO 2025

In this ESTRO 2025 interview, Prof. Murray Brunt of the University of Keele and Chief Investigator of the FAST-FORWARD trial discusses key advances in breast cancer radiotherapy and the future of precision treatment.

✅ The FAST-FORWARD trial demonstrated that delivering whole-breast or chest wall radiotherapy in just five fractions over one week is as effective as traditional three-week schedules.
✅ Ongoing questions remain regarding tumor boost dosing and internal mammary lymph node irradiation—areas now being addressed in the newly launched FAST-FORWARD BOOST trial, led by Prof. Anna Kirby.
✅ The BOOST trial will recruit nearly 5,000 higher-risk patients internationally to explore simultaneous integrated boost and nodal irradiation strategies.
✅ Prof. Brunt emphasizes a shift toward precision breast cancer treatment, aiming to avoid overtreatment and optimize both radiotherapy and systemic therapy decisions.

🎙️ Insightful perspectives on hypofractionation, individualized care, and the evolving landscape of breast radiotherapy from one of the field’s leading experts.

📍 Filmed at ESTRO 2025 | Powered by OncoDaily

#ESTRO2025 #FASTFORWARDTrial #FASTFORWARDBOOST #BreastCancerRadiotherapy #Hypofractionation #PrecisionRadiotherapy #OncoDaily

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”